ARIBIO
Live / Registered — Registered (as of 07 Apr 2026)
What this means for you
Registered since 07 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 98268917
- Registration number
- 8200652
- Mark type
- Word mark
- Filed
- 14 Nov 2023
- Published for opposition
- 16 Sept 2025
- Registered
- 07 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Apr 2032 (grace period to 07 Oct 2032)
- Attorney of record
- minchul yang
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of degenerative brain disease; research and development services in the field of Alzheimer's disease; research and development services in the field of dementia; pharmaceutical research and development in the field of Alzheimer's disease; pharmaceutical research and development in the field of dementia; pharmaceutical research and development; biotechnology research and development
Owner
- ARIBIO Co., Ltd, Seongnam-si, Gyeonggi, KR
- ARIBIO Co., Ltd, Seongnam-si, Gyeonggi, KR
- ARIBIO Co., Ltd, Seongnam-si, Gyeonggi, KR
Prosecution history
- 07 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 13 Mar 2026 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 13 Nov 2025 — NOTICE OF ALLOWANCE CANCELLED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Nov 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 16 Jul 2025 — LETTER OF SUSPENSION E-MAILED
- 16 Jul 2025 — SUSPENSION LETTER WRITTEN
- 16 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED